Progeria: gene therapy gives hope
Gene therapy has significantly increased the life expectancy of mice with a progeria analogue. Clinical trials are next in line.
01.11.2011Gene therapy has significantly increased the life expectancy of mice with a progeria analogue. Clinical trials are next in line.
01.11.2011Aging can be slowed down without limiting calorie intake. The key to slowing down the aging process is to maintain the activity of the Tsa 1 enzyme in cells.
01.11.2011Bacteria that were considered immortal are also aging. This happens due to asymmetric division, in which one of the daughter cells gets almost all the non-genetic damage accumulated during the life of the mother cell.
28.10.2011Bacterial infection suffered by newborns causes changes in the immune system of the brain, impairing cognitive abilities and memory in adulthood.
28.10.2011A group of researchers who will read the genomes of 100 centenarians with the best indicators of speed, accuracy, completeness and cost of sequencing will receive $10 million as a prize.
27.10.2011Following seven simple rules can increase a person's healthy life expectancy by 40-50 years. How to do it has finally ceased to be a secret!
26.10.2011High-tech developments are in demand by Russian consumers, so it is necessary to discard pessimism about the demand for innovations in the country, Anatoly Chubais believes.
26.10.2011With age, the number of points received by pilots during the aptitude test on the flight simulator gradually decreases. One of the common polymorphisms of the gene encoding brain neurotrophic factor (BDNF) accelerates this process by 3 times.
26.10.2011On November 11-12, 2011, Nazarbayev University will host the First International Scientific Conference on Regenerative Medicine and Quality Longevity within the framework of the 20th anniversary of independence of the Republic of Kazakhstan.
25.10.2011The various conditions in which children from affluent and poor families grow up are "remembered" in their organisms at the epigenetic level for the rest of their lives – in the form of differences in DNA methylation.
25.10.2011Differences in the state of the immune system will make it possible to identify people who have every chance of maintaining good health and a clear mind until old age, as well as those who need timely prevention of age-related diseases.
25.10.2011This year, the main topic of the Forum will be the demand for innovation. Its participants will discuss the prospects of using nanotechnology in a wide range of industries – from construction and mechanical engineering to electronics and pharmaceuticals.
25.10.2011Two existing tests detect human papillomavirus with a sufficiently high sensitivity – 84 and 91%. In addition, all the women who tried the test for self-conducting called this method simple and easy.
25.10.2011We invite you to take part in the sixth international conference "Modern Achievements of Bionanoscopy", which will be held in June 2012 at Lomonosov Moscow State University.
25.10.2011Testosterone levels do not affect life expectancy. Moreover, we do not know anything about whether it does not lead to premature death itself if you start taking it in the hope of improving the heart.
24.10.2011People allow themselves to eat unhealthy food, hoping to neutralize its harmful effects with the help of "healthy" products. But the belief in their enormous benefits can be not just useless, but also dangerous to health.
21.10.2011The competition accepts research, design and abstract works of schoolchildren devoted to the issues of nano-, bio-, info-, cognitive sciences and technologies.
21.10.2011The ranking of the 50 largest investors in R&D includes 15 European companies, 17 American and 13 Japanese. The top 5 included 2 pharmaceutical companies: Roche (Switzerland) and Pfizer (USA). In 14th place is the French pharmaceutical company Sanofi.
21.10.2011Russia has a huge innovative potential, good scientific traditions, and a clear understanding by the country's leadership of the need to modernize pharmaceutical enterprises... but investments in the Russian pharmaceutical market account for less than 1% of the global total.
20.10.2011The American company NeoStem has signed an unprecedented contract in the field of research of stem cells obtained from adults. The Catholic Church became its partner.
20.10.2011You can write to the editor at:
vm@vechnayamolodost.ruThe editors of Eternal Youth are preparing a useful and interesting mailing list. You can get it if you leave your mail.